IVP News & Events

Inspire Veterinary files to sell 200M shares of Class A common stock for holders

Inspire Veterinary Partners announces the creation of an online pet pharmacy, offering veterinary professionals and their clients access to top-of-the-line prescription and over-the-counter pet healthcare products. The launch of the online pharmacy is expected in the first quarter of 2026. Leveraging its veterinary expertise as an owner and operator of veterinary hospitals, as well as building on the extensive relationships the leadership team has within the veterinary medicine industry, the Company will launch the pharmacy offering within specific geographies in the United States, followed by expansion throughout 2026 into national distribution. The pharmacy will offer both prescription medications and over-the-counter products designed to enhance the health and vitality of pets.

Accomplishments to date include: The highest new client growth in more than a year, with clinics across the portfolio achieving positive new client growth compared to 2024 and prior. Completion of an enterprise-wide rollout of cloud-based Electric Medical Record and Practice Management Software across all clinics. Deployment of Artificial Intelligence-based transcription for medical notes, enabling enhanced productivity and efficiency across the company's business units. Record breaking veterinarian hiring with nine new doctor starts since the beginning of 2025. Completion of the company's fifth acquisition in the state of Florida. Signing of a Letter of Intent for a planned acquisition of the company's first location in New Jersey, which will be the Company's 15th location nationwide. A return to positive revenue comps as reported in Q2 2025. Deployment of infrastructure investments including a new talent management system; new engagement, recognition and incentive-based pay structures; new finance professionals and enhancements to the company's purchase and inventory management systems; new investor relations and investment banking partnerships. CEO Kimball Carr commented, "Inspire is back to growth and we are better positioned for success than ever before. Following our letter to shareholders earlier in 2025, we are very excited to continue to share the progress Inspire is making and how we're seeing the benefits of our collective work reflected in our business. The company is consistently delivering positive results, new growth across a wide array of measures and KPIs ,and there is maturity in our systems and leadership team, which are delivering results on a daily basis. We're looking forward to finishing strong in 2025 and springing forward toward increased growth in 2026."

Inspire Veterinary Partners received formal notification on August 26, 2025 from the Nasdaq Stock Market determining that the Company now complies with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5M in stockholders' equity.On April 10, 2025, the Company received formal notification from Nasdaq citing that it was out of compliance and needed to meet the requirements set forth under Listing rules 5550 (b)(1), 5550 (b)(2), or 5550 (b)(3). Confirmation of compliance was based on the Company's Form 8-K dated August 20, 2025.